If your goal is long-term wellness, better recovery, improved energy, body-composition support, or age-related hormone optimization, peptide therapy may be a worthwhile investment when prescribed and monitored by a qualified provider
For instance, the FDA's approval of GLP-1 agonists for both type 2 diabetes and obesity has prompted professional organizations to update their clinical guidelines, outlining specific recommendations for their use in various patient populations
This is why sourcing diligence and independent verification matter for research-grade material
Triple-Hormone Combination Retatrutide Induces 24% Body Weight Reduction
Cytidine-5'-diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy
That being said, human research in this area is limited and more is needed before strong conclusions can be drawn